June Carnegie

Managing Director

june.carnegie@sentrixhealth.com

June brings more than 20 years' industry experience that spans professional, direct-to-patient, and managed markets communications. She has motivated and mentored multiple agency teams to produce award-winning work for therapies such as the SSRIs Celexa and Lexapro, the triptans Imitrex and Treximet, the hospital IV solutions Angiomax and Cleviprex, Kogenate, BeneFIX, Refacto, and Pegasys, as well as global Haem Onc launches for Celgene's Revlimid, Istodax, and Pomalyst. June has led high-profile launches such as Advair Diskus for Asthma (awarded Launch of the Year by MM&M and Med Ad News), BOTOX Cosmetic, and Crestor. Direct organic growth included being awarded Advair Diskus for Pediatric Asthma and Advair Diskus for COPD—maintaining all 3 indications for 8 years. Her experience is rounded out with "me too" products such as Zegerid, and OTC brands that included Aleve, Bayer Aspirin, Flintstones Vitamins, and Citracal.

At Sentrix, June leads a talented team of account execs and creatives on Combivent Respimat (a novel inhaler)—an important respiratory launch at Boehringer Ingelheim, Abilify Maintena for schizophrenia, Pfizer's Heme/Oncology franchise (including Bosulif, Mylotarg, Inotuzumab, and SMO), and DHCP promotion on J&J's mouthwash, Listerine.

June prides herself on establishing open communication with her clients to maintain fresh insight and relevancy in order to meet immediate and future needs. She has been commended by clients for developing highly motivated teams that yield superior and timely results. These teams have been rewarded with just about every major industry award available.